HBM Healthcare Investments actively invests in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas. The company holds and manages an international portfolio of promising companies.
Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided on their strategic directions. This is what makes HBM Healthcare Investments an interesting alternative to investing in big pharma and biotech companies. HBM Healthcare Investments has an international shareholder base and is listed on SIX Swiss Exchange (ticker: HBMN).
Bundesplatz 1, 6300 Zug – Switzerland
|Date||Trading entity / Person||Association||Trade type||Volume|
|22.08.23||None||Non-Executive member||Sell||CHF 54,900.00|
|21.08.23||None||Non-Executive member||Sell||CHF 11,407.00|
|18.08.23||None||Non-Executive member||Sell||CHF 38,260.00|
|10.08.23||None||Non-Executive member||Sell||CHF 13,601.00|
|26.05.23||None||Executive member||Buy||CHF 61,058.40|
|21.06.22||None||Non-Executive member||Buy||CHF 54,200.00|
|17.03.22||None||Non-Executive member||Buy||CHF 82,050.00|
|07.03.22||None||Executive member||Buy||CHF 85,579.00|
|25.02.22||None||Non-Executive member||Buy||CHF 82,644.00|
|17.02.22||None||Non-Executive member||Buy||CHF 59,200.00|
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.